Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

SOFOSBUVIR

SOFOSBUVIR

Standard Dose
400MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview SOFOSBUVIR is listed in Drugs@FDA under application 211353 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient SOFOSBUVIR Form and strength TABLET;ORAL - 400MG Sponsor TEVA PHARMS USA INC Submission history Latest submission status date: 2022-01-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview SOFOSBUVIR is listed in Drugs@FDA under application 211353 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SOFOSBUVIR Form and strength TABLET;ORAL - 400MG Sponsor TEVA PHARMS USA INC Submission history Latest submission status date: 2022-01-27 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.